Hyderabad, March 27 -- Shreehas Tambe has been appointed Chief Executive Officer (CEO) and Managing Director (MD) of Biocon Limited, effective April 1, 2026, the company announced on Friday.
The appointment follows approvals from the Board and the Nomination and Remuneration Committee.
Kedar Upadhye has also been named Chief Financial Officer (CFO) of the company.
Tambe will be the first CEO to lead the integrated Biocon following the consolidation of its biosimilars and generics businesses, aimed at strengthening scale and global competitiveness.
The move comes as part of the integration of Biocon Biologics as a wholly owned subsidiary, creating a unified corporate structure.
Executive Chairperson Kiran Mazumdar-Shaw said the integrat...